GLP-1受体激动剂,GLP-1 receptor agonist
1)GLP-1 receptor agonistGLP-1受体激动剂
1.The aim of this project is to establish a GLP-1 signaling pathway targeted cell model, for screening the new class ofGLP-1 receptor agonists as anti-diabetic candidates.建立以GLP-1信号通路为靶点的药物筛选细胞模型,用于筛选GLP-1受体激动剂类的新型抗糖尿病药物。
2)GLP-1GLP-1受体
1.nGLP-1R s Expression and Purification in a Prokaryote Expression System;GLP-1受体N端的原核表达与纯化
英文短句/例句
1.Construction and Application of siRNA Plasmid for Glucagons-like Peptide 1 ReceptorGLP-1受体siRNA表达载体的构建
2.nGLP-1R s Expression and Purification in a Prokaryote Expression System;GLP-1受体N端的原核表达与纯化
3.A novel cell model targeted on GLP-1 receptor for application to anti-diabetic candidates screening以GLP-1受体为靶点的药物筛选细胞模型的建立和应用
4.High Throughput Screening of Agonist for GLP-1 Receptor from Chinese Traditional Medicine Library;中药提取库中胰升血糖素样肽-1（GLP-1）受体激动剂的高通量筛选
5.Effects of Glucagon Like Peptide 2 on Gastrointestinal Mucosa and Its Receptor Distribution in MiceGLP-2对小鼠胃肠粘膜作用及其受体分布的初步研究
6.Performance of bacterial reverse mutation test in GLP systemGLP体制下细菌回复突变试验的实施
7.GLP-1 Analogues-Liraglutide for Type 2 Diabetic: Systemetic ReviewGLP-1类似物-Liraglutide治疗2型糖尿病的系统评价
8.The Current Situation, Problems and Their Countermeasures for the Construction of the GLP Quality Systems in China;我国GLP质量体系建设的现状、问题与对策
9.Application of GLP Principle in the Establishment of University Students Management System;GLP管理原则在学生管理体系建设中的运用
10.Studies of Polypeptide Drugs "Short GLP-1" on Key Problems of Detected Methods;多肽类药物“截短型GLP-1”检测方法相关关键性问题探索
11.Research Progress in GLP-1 Analogues with Type 2 Diabetes Mellitus and Its Chronic ComplicationsGLP-1类似物与2型糖尿病及其慢性并发症的研究进展
12.Correlation between GLP-1 and CRP in patients with diabetic cardiomyopathy糖尿病性心肌病患者GLP-1与C-反应蛋白的相关性分析
13.Effects of gastric bypass on GLP-1 secretion and blood glucose in type 2 diabetic rats胃转流术对2型糖尿病大鼠血糖和GLP-1分泌的影响
14.Position: Stand by side and face the beneficiary.（1） 体位：体侧位，面向受术者.
15.Association of β-arrestom and TRAF6 Negatively Regulates Toll-like Receptor-interleukin 1 Receptor Signaling;β-Arrestin调控Toll样受体—白介素1受体的信号转导
16.The Effects of GLP-1 to the Expression of Glycogen Synthetase and the Study with MAPK Cell Signalling Pathway in Muscle CellsGLP-1对骨骼肌细胞糖原合成酶表达的影响及其与MAPK信号途径的研究
17.The Experimental Study of Triggering Receptor Expressed on Myeloid Cells-1 in the Endotoxin Tolerance THP-1 Cell Line;内毒素耐受的THP-1细胞系髓系细胞触发受体1表达的实验研究
18.XBP-1 Enhances the Transcriptional Activity of Estrogen Receptor α;XBP-1能提高雌激素受体ERα的转录活性
相关短句/例句
GLP-1GLP-1受体
1.nGLP-1R s Expression and Purification in a Prokaryote Expression System;GLP-1受体N端的原核表达与纯化
3)cannabinoid receptor 1 agonist大麻素受体1激动剂
4)receptor agonists受体激动剂
1.Purpose To build a three dimensional structure activity relationship model of the title compounds and gain further insights into requirements for potential nonsteroidal progesteronereceptor agonists.目的 建立非甾体类孕酮受体激动剂5-亚苄基-1,2-二氢-5H-苯并吡喃并[3,4-f]喹啉衍生物的三维 定量构效模型,为设计高效的非甾体类孕酮受体激动剂提供理论依据。
5)M1 receptor agonistM1受体激动剂
1.3-(3-Chloro-1,2,5-thiadiazol-4-yl)pyridine,which is a key intermediate of selectiveM1 receptor agonist xanomeline,was synthesized from 3-pyridine carboxaldehyde,sodium cyanide,and sulfur chloride.以3-吡啶甲醛为原料,与氰化钠、一氯化硫反应合成选择性M1受体激动剂占诺美林的关键中间体3-(3-氯-1,2,5-噻二唑-4-基)吡啶,目标化合物的结构经1H-NMR谱确证。
2.In this paper, the recent research progress in drugs for treatment of AD and their mechanisms are reviewed, including AChE inhibitor,M1 receptor agonist,antioxidants,nerve growth factor,calcium regulator and so on.综述了近5年来治疗AD药物的研究进展,根据作用机制的不同对临床应用的抗AD和有促智活性的药物进行分类详述,主要分为乙酰胆碱酯酶抑制剂等改善胆碱功能的药物、M1受体激动剂、抗氧化药物、消炎镇痛药物、抑制Aβ蛋白形成的药物、神经生长因子、钙调节剂、晚期糖基化终产物(AGE)抑制剂以及中药复方等几类。
6)β2-agonistsβ2-受体激动剂
1.The method for determination ofβ2-agonists (salbutamol, terbutaline, cimaterol, cimbuterol, ractompamine, clenbuterol, bromobuterol, isoxsuprine, mabuterol, mapenterol, bromclenbuterol) residues in liver and meat of pig was developed by HPLC/MS-MS.建立了同时检测11种β2-受体激动剂物质(包括沙丁胺醇、特布它林、塞曼特罗、塞布特罗、莱克多巴胺、克仑特罗、溴布特罗、苯氧丙酚胺、马布特罗、马贲特罗、溴代克仑特罗)在猪肉及猪肝脏中残留量的液相色谱-串联质谱(HPLC/MS-MS)方法。
2.A delicate method has been developed for the simultaneous determination of 23β2-agonists and 5 β-blockers illegal drugs in muscle tissues by high performance liquid chromatography-linear ion trap mass spectrometry using isotope dilution technique.利用高效液相色谱-线性离子阱质谱(HPLC-ITMS)以同位素稀释技术测定了肌肉组织中23种β2-受体激动剂及5种β-阻断剂。
延伸阅读
[styrene-(2-vinylpyridine)copolymer]分子式：分子量：CAS号：性质：学名苯乙烯-2-乙烯吡啶共聚物。微黄色粉末或透明小颗粒晶体。无臭，无味。不溶于水，溶于酸、乙醇、丙酮、氯仿。有抗水、防潮性能，适用于多种药片的包衣等。
